Researchers have identified 64 genomic regions that contain genetic variants associated with an increased risk of developing bipolar disorder. The study also revealed a genetic overlap between bipolar disorder and other psychiatric disorders.
Study adds to the growing evidence Bartonella infection is associated with neuropsychological symptoms in addition to dermatological symptoms.
Researchers developed an artificial intelligence system that can detect day-to-day changes in speech that may hint of mental health decline.
A large scale genome-wide study suggest the origins of anorexia include both metabolic and psychiatric components.
Researchers conclude many psychiatric diagnoses are scientifically worthless as tools for identifying discrete mental health disorders.
MDMA, a psychedelic drug, has successfully been used to reopen the 'critical period' of learning the reward values of social behaviors. Researchers report, in mature mice given MDMA, oxytocin triggers signaling in synapses that help encode social learning and memory, a process that does not usually occur in older animals. The findings could help in the development of treatments for PTSD and other disorders.
A new phenotype atlas assisted researchers in identifying 30 genes associated with an increased risk of developing schizophrenia. Single-cell RNA sequencing revealed an essential role for the transcription factor znf536 in the development of forebrain neurons associated with social behavior and stress.
Transcranial alternating current brain stimulation (tACS) significantly reduced symptoms in people diagnosed with major depressive disorder in a pilot clinical trial.
Risks for autism and depression are higher if one’s mother was in a hospital with an infection during pregnancy according to a new study.
A new study adds to growing evidence that altering diet and lifestyle could help to improve symptoms of depression. The study reports, making simple dietary changes, such as eating more nutrient dense meals and cutting back on refined sugars, can help to reduce symptoms associated with anxiety and depression.
Using transcranial magnetic stimulation, researchers have successfully restored network function between the prefrontal cortex and cerebellum, helping to improve symptoms in those with treatment resistant schizophrenia.
Researchers report 1 in 5 people are at risk of experiencing mental health conditions, such as PTSD or major depressive disorder, within 6 months of suffering mTBI.
